Eur Rev Med Pharmacol Sci 2015; 19 (22): 4207-4209

The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology

M. Berretta, B. Stanzione, R. Di Francia, U. Tirelli

Department of Medical Oncology, National Cancer Institute, Aviano (PN) Italy. mberretta@cro.it

Free PDF Download

To cite this article

M. Berretta, B. Stanzione, R. Di Francia, U. Tirelli
The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 22
Pages: 4207-4209

Keywords Related articles:

  1. The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology
  2. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma
  3. Study on the relationship between the RASSF10 gene and the biological behavior of hepatocellular carcinoma cells
  4. Analysis of the relationship between microRNA-31 and interferon regulatory factor-1 in hepatocellular carcinoma cells
  5. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma